Healthcare & Life Sciences
Ambrosia Bio
Israelambrosia.bio/
Ambrosia Bio is a Healthcare & Life Sciences startup based in Israel, most recent round Series B, 1 tracked investor.
Activeseries-b
series-b
Stage
1
Investors
About Ambrosia Bio
Based in Israel, Ambrosia Bio is a startup. Its most recent tracked round is Series B. Brouky classifies it under Healthcare & Life Sciences. Brouky records 1 investor associated with the company.
Ambrosia Bio produces rare sugars such as Allulose in large quantities, providing a natural sweetener with low to no calories that is safe for diabetic patients and mimics the taste and texture of sugar.
Explore Ambrosia Bio's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.